HUU
6-chloranyl-2-ethyl-N-[[4-[4-[4-(trifluoromethyloxy)phenyl]piperidin-1-yl]phenyl]methyl]imidazo[1,2-a]pyridine-3-carboxamide
| Created: | 2021-02-04 |
| Last modified: | 2021-08-04 |
Find Related PDB Entry |
|---|
Find related ligands: |
|---|
Chemical Details | |
|---|---|
| Formal Charge | 0 |
| Atom Count | 67 |
| Chiral Atom Count | 0 |
| Bond Count | 71 |
| Aromatic Bond Count | 22 |
Chemical Component Summary | |
|---|---|
| Name | 6-chloranyl-2-ethyl-N-[[4-[4-[4-(trifluoromethyloxy)phenyl]piperidin-1-yl]phenyl]methyl]imidazo[1,2-a]pyridine-3-carboxamide |
| Synonyms | Telacebec |
| Systematic Name (OpenEye OEToolkits) | 6-chloranyl-2-ethyl-~{N}-[[4-[4-[4-(trifluoromethyloxy)phenyl]piperidin-1-yl]phenyl]methyl]imidazo[1,2-a]pyridine-3-carboxamide |
| Formula | C29 H28 Cl F3 N4 O2 |
| Molecular Weight | 557.006 |
| Type | NON-POLYMER |
Chemical Descriptors | |||
|---|---|---|---|
| Type | Program | Version | Descriptor |
| SMILES | CACTVS | 3.385 | CCc1nc2ccc(Cl)cn2c1C(=O)NCc3ccc(cc3)N4CCC(CC4)c5ccc(OC(F)(F)F)cc5 |
| SMILES | OpenEye OEToolkits | 2.0.7 | CCc1c(n2cc(ccc2n1)Cl)C(=O)NCc3ccc(cc3)N4CCC(CC4)c5ccc(cc5)OC(F)(F)F |
| Canonical SMILES | CACTVS | 3.385 | CCc1nc2ccc(Cl)cn2c1C(=O)NCc3ccc(cc3)N4CCC(CC4)c5ccc(OC(F)(F)F)cc5 |
| Canonical SMILES | OpenEye OEToolkits | 2.0.7 | CCc1c(n2cc(ccc2n1)Cl)C(=O)NCc3ccc(cc3)N4CCC(CC4)c5ccc(cc5)OC(F)(F)F |
| InChI | InChI | 1.03 | InChI=1S/C29H28ClF3N4O2/c1-2-25-27(37-18-22(30)7-12-26(37)35-25)28(38)34-17-19-3-8-23(9-4-19)36-15-13-21(14-16-36)20-5-10-24(11-6-20)39-29(31,32)33/h3-12,18,21H,2,13-17H2,1H3,(H,34,38) |
| InChIKey | InChI | 1.03 | OJICYBSWSZGRFB-UHFFFAOYSA-N |
Drug Info: DrugBank
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
| DrugBank ID | DB17754 |
|---|---|
| Name | Telacebec |
| Groups | investigational |
| Synonyms |
|
| CAS number | 1334719-95-7 |
Related Resource References
| Resource Name | Reference |
|---|---|
| PubChem | 68234908 |
| ChEMBL | CHEMBL3298910 |














